Here is what I am reading today:
““This isn’t ready for application in the clinic yet, but as we get a better feel for where these and other hubs are found in the brain, they may factor into surgical decision-making,” said co-senior author Steven Petersen, PhD, the James S McDonnell Professor of Cognitive Neuroscience in Neurology. “The risks of surgeries to these sites could include significant impairment of attention, memory, language, speech and many other cognitive functions.””
“The researchers hope that this unifying theory, if validated, could offer new strategies for treating autism.
“At the moment, the treatments that have been developed are driven by the end symptoms. We’re suggesting that the deeper problem is a predictive impairment problem, so we should directly address that ability,” says Pawan Sinha, an MIT professor of brain and cognitive sciences and the lead author of a paper describing the hypothesis in the Proceedings of the National Academy of Sciences this week.”
“Society for Neuroscience archival interview with American sleep researcher William C. Dement. He founded the Sleep Research Center, the world’s first sleep laboratory, at Stanford University. The interview took place July 21-22, 2004. This video is part of the Society for Neuroscience’s autobiography series, “The History of Neuroscience in Autobiography,” detailing the lives and discoveries of eminent senior neuroscientists.”
“”We have now shown that one way maternal inflammation could result in larger brains and, ultimately, autistic behavior, is through the activation of the neural stem cells that reside in the brain of all developing and adult mammals,” said Dr. Harley Kornblum, the paper’s senior author and a director of the Neural Stem Cell Research Center at UCLA’s Semel Institute for Neuroscience and Human Behavior.”
“Blood-brain barrier (BBB) damaging during ischemia may induce devastating consequences like cerebral edema and hemorrhagic transformation. This study presents a novel strategy for dynamically imaging of BBB damaging with PEGylated supermagnetic iron oxide nanoparticles (SPIONs) as contrast agents.”